Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05905055
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-03-02
Brief Title:
P3 Study to Assess Efficacy and Safety of CefepimeNacubactam and AztreonamNacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Sponsor:
Meiji Seika Pharma Co Ltd
Organization:
Meiji Seika Pharma Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Complicated Intra-abdominal Infection |
| Complicated Urinary Tract Infection |
| Acute Pyelonephritis |
| Hospital-acquired Bacterial Pneumonia |
| Ventilator-associated Bacterial Pneumonia |
Keywords: